Cardiometabolic Health and Inflammatory Resolution
ConditionVolunteers
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-65
SponsorGöteborg University
About this trial
The aim of this study is to determine how inflammatory resolution impacts cardiometabolic health and disease in subjects that are either lean (18.5-24.9 kg/m2), overweight (25.0-29.9 kg/m2) or obese (\>30.0 kg/m2).
Eligibility criteria
Qualifiers
Informed signed consent has been obtained from the volunteer.
The volunteer has a BMI greater than 18.5 kg/m2
Disqualifiers
The study staff contacting a potential participant perceives that the individual has difficulty understanding the information.
An MD determines that the individual is on too many medications to participate
The individual takes a medication that is approved by the MD, but he/she is not willing or not able to wait with any potential morning medication until after their fasted blood-draw.
The individual is younger than 18 years (relevant for the FAINT-1 and FAINT-2 cohorts)
Trial design
Treatments tested in this trial
- Not listed
Trial groups
200 Participants
are grouped into 6 trial groups6
Trial groupsSee each trial group below.
Sponsors and collaborators
Source ClinicalTrials.gov